Windtree Therapeutics, Inc.

8-K Entered a material agreement Jul 22, 2026 8-K Director or officer change Jan 7, 2026 8-K Took on a direct financial obligation; Unregistered sale of equity Dec 2, 2025 10-Q Quarter ended 2025-09-30 Nov 19, 2025 8-K Took on a direct financial obligation; Unregistered sale of equity Oct 16, 2025 8-K Entered a material agreement Oct 6, 2025 8-K Director or officer change Sep 8, 2025 8-K Shareholder vote results Sep 2, 2025 8-K Delisting notice or listing-rule failure Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 19, 2025 8-K Other events Aug 8, 2025 8-K Regulation FD disclosure Aug 5, 2025 8-K Director or officer change Aug 4, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jul 24, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Regulation FD disclosure Jul 17, 2025 8-K Entered a material agreement; Unregistered sale of equity Jul 3, 2025 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Director or officer change Jun 27, 2025 8-K Delisting notice or listing-rule failure Jun 20, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure; Other events Jun 11, 2025 8-K Results of operations (earnings release); Delisting notice or listing-rule failure May 16, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure May 1, 2025 8-K Entered a material agreement; Unregistered sale of equity Apr 30, 2025 8-K Director or officer change Apr 18, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Results of operations (earnings release) Apr 15, 2025 8-K Entered a material agreement; Took on a direct financial obligation Apr 10, 2025 8-K/A Regulation FD disclosure Mar 25, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure; Other events Mar 24, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Feb 18, 2025 8-K/A Entered a material agreement; Unregistered sale of equity; Other events Feb 14, 2025 8-K Shareholder vote results Feb 3, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 27, 2025 8-K Director or officer change; Other events Jan 13, 2025 8-K Other events Jan 8, 2025 8-K Delisting notice or listing-rule failure Dec 5, 2024 8-K Other events Dec 4, 2024 8-K Results of operations (earnings release); Delisting notice or listing-rule failure Nov 27, 2024 10-Q Quarter ended 2024-09-30 Nov 26, 2024 8-K/A Director or officer change Nov 15, 2024